Scientists find gut-linked IBD genes
Scientists identified the first genetic markers tied to inflammatory bowel disease that directly impact gut cells. The discovery provides new insights into how the condition develops and potential treatment targets.
A study in Nature on June 3, 2026, examined gene activity in 2.2 million individual cells from gut biopsies and blood samples of 421 people, including 125 with Crohn’s disease. The analysis mapped how inherited genetic variants influence specific cell types, uncovering two previously overlooked mechanisms driving inflammation.
From Risk Regions to Specific Genes
For years, researchers knew certain DNA variants correlated with higher IBD risk but struggled to explain their function. Most variants lie outside protein-coding regions, making them difficult to interpret.
“Genome-wide association studies showed where IBD risk resides in the genome, but this work reveals which genes these variants disrupt and in which cells,” said Dr. Carl Anderson, co-senior author at the Wellcome Sanger Institute.
The team created IBDverse, the largest single-cell analysis of gut tissue ever assembled. By studying gene activity in individual cells instead of mixed samples, they identified 74 gene regulatory regions linked to inherited IBD risk—areas previously unexplained.
Unexpected Cell Types Emerge as Key Players
The results pointed to cell types not previously highlighted in IBD research. Dendritic cells, which monitor the gut and guide immune responses, showed altered activity in genes tied to the notch signaling pathway.
Related: Seven HGH Suppliers Compared: Products, Support, and Pricing
“This could weaken the immune system’s ability to balance attacking threats and tolerating harmless food or bacteria,” the study authors noted.
In the gut lining, risk variants disrupted the Wnt signaling pathway, which controls cell growth and renewal. This suggests IBD may arise not only from immune dysfunction but also from the gut’s impaired ability to repair itself.
While most people with IBD carry some of these genetic variants, not everyone with them develops the disease. The study clarifies which genes and cell types are likely involved when inflammation occurs but doesn’t alter that reality.
For drug development, the findings offer guidance. Several identified genes are already targeted by existing IBD medications, such as ITGA4 (vedolizumab) and JAK2 (tofacitinib).
An interesting connection involved metformin, a diabetes drug that has reduced IBD symptoms in some patients. While the study didn’t directly examine metformin, it identified pathways the drug is known to affect, hinting at a possible mechanism for its benefits.
The study’s scale was unprecedented. “When we began planning, single-cell sequencing projects typically included tens of individuals,” said Dr. Tim Raine, co-senior author and consultant gastroenterologist at Cambridge University Hospitals. “We needed a much larger sample to answer these questions.”
Related: Gums linked to overall body health
That scale allowed the detection of patterns smaller studies would have missed. While earlier research had linked 321 genetic regions to IBD, this work connected 180 of them to specific genes and cell types. The remaining 141 regions remain unexplored.
The findings don’t predict who will develop IBD. Genetics alone can’t explain why some with high-risk variants stay healthy while others with few known risks fall ill. However, by narrowing the cellular processes involved, the study provides clearer targets for future research.
“Many of the newly identified genes regulate pathways previously overlooked in IBD risk,” the study authors wrote. “These associations also appeared in specific gut cell types, which aren’t commonly linked to the disease.”
Next, researchers will test whether these pathways—such as notch signaling in dendritic cells or impaired cell renewal in the gut lining—actually drive inflammation in living systems. If confirmed, they could lead to entirely new treatments.
The study now stands as the most detailed map of how inherited risk translates into cellular dysfunction in IBD. For the millions living with Crohn’s disease or ulcerative colitis, this map may guide the way toward more effective therapies. Regular dental cleanings can also support overall health, as gum disease has been linked to systemic inflammation.
